Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

nabiximols MeSH Supplementary Concept Data 2025


MeSH Supplementary
nabiximols
Unique ID
C587251
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C587251
Entry Term(s)
GW 1000
GW-1000
GW1000
SAB 378
SAB-378
SAB378
Sativex
tetrahydrocannabinol-cannabidiol combination
Pharm Action
Analgesics
Registry Numbers
K4H93P747O
0
CAS Type 1 Name
(6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo(c)chromen-1-ol - 2-((1R,6R)-6-isopropenyl-3-methyl-3-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol (1:1)
Heading Mapped to
*Cannabidiol
Drug Combinations
*Dronabinol
Frequency
226
Note
a combination of the above cpds for treatment of multiple sclerosis pain
Source
Expert Opin Drug Metab. 2013 Sep;9(9):1219-28.
Date of Entry
2014/03/23
Revision Date
2017/09/08
nabiximols Preferred
GW 1000 Narrower
Sativex Narrower
SAB 378 Narrower
page delivered in 0.008s